NASDAQ:IRIX - Nasdaq - US4626841013 - Common Stock - Currency: USD
Overall IRIX gets a fundamental rating of 1 out of 10. We evaluated IRIX against 188 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of IRIX have multiple concerns. IRIX does not seem to be growing, but still is valued expensively.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -20.83% | ||
ROE | -104.09% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 41.18% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.53 | ||
Debt/FCF | N/A | ||
Altman-Z | -1.88 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.95 | ||
Quick Ratio | 1.27 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
NASDAQ:IRIX (5/30/2025, 8:05:40 PM)
0.998
-0.05 (-4.95%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 0.34 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 2.45 | ||
P/tB | 3.59 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -20.83% | ||
ROE | -104.09% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 41.18% | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.53 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | N/A | ||
Cap/Sales | N/A | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 1.95 | ||
Quick Ratio | 1.27 | ||
Altman-Z | -1.88 |